This partnership is set to meet the growing demand for innovative life science research solutions in the Vietnamese market
He did Master’s of Pharmacy (Pharmaceutical Technology, Formulations) from National Institute of Pharmaceutical Education and Research, Mohali and Bachelor of Pharmacy from Osmania University
In Q2 FY25, our crop protection segment reported revenue of Rs. 159 crore, with an EBIT margin of 5%
He will join in place of Anil Arora, current President- Formulations Operations who will be superannuating in November, 2024
We now rank 3rd in pharmaceutical production by volume and 14th by value
Expansion includes a new 5-story, 136k sq. ft. multipurpose building in Sejong
Studies suggest that the protein Sclerostin plays a key role in the dysregulation of bone metabolism
Aragen Life Sciences is the first Indian CRDMO to receive SBTi approval
Investment in new plant meets increasing demand for functional excipients for oral drug delivery
Subscribe To Our Newsletter & Stay Updated
